154 related articles for article (PubMed ID: 32355475)
1. Pathophysiology of Alloimmunization.
Molina-Aguilar R; Gómez-Ruiz S; Vela-Ojeda J; Montiel-Cervantes LA; Reyes-Maldonado E
Transfus Med Hemother; 2020 Apr; 47(2):152-159. PubMed ID: 32355475
[TBL] [Abstract][Full Text] [Related]
2. Divergent CD4
Khelfa M; Leclerc M; Kerbrat S; Boudjemai YNS; Benchouaia M; Neyrinck-Leglantier D; Cagnet L; Berradhia L; Tamagne M; Croisille L; Pirenne F; Maury S; Vingert B
Front Immunol; 2023; 14():1165973. PubMed ID: 37701444
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.
Nickel RS; Horan JT; Fasano RM; Meyer E; Josephson CD; Winkler AM; Yee ME; Kean LS; Hendrickson JE
Am J Hematol; 2015 Dec; 90(12):1135-41. PubMed ID: 26361243
[TBL] [Abstract][Full Text] [Related]
4. Hemin controls T cell polarization in sickle cell alloimmunization.
Zhong H; Bao W; Friedman D; Yazdanbakhsh K
J Immunol; 2014 Jul; 193(1):102-10. PubMed ID: 24879794
[TBL] [Abstract][Full Text] [Related]
5. Optimal blood grouping and antibody screening for safe transfusion.
Makarovska-Bojadzieva T; Blagoevska M; Kolevski P; Kostovska S
Prilozi; 2009 Jul; 30(1):119-28. PubMed ID: 19736535
[TBL] [Abstract][Full Text] [Related]
6. Red Cell Alloantibodies in Multiple Transfused Thalassaemia Patients.
Chaudhari CN
Med J Armed Forces India; 2011 Jan; 67(1):34-7. PubMed ID: 27365758
[TBL] [Abstract][Full Text] [Related]
7. RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota.
Winters JL; Pineda AA; Gorden LD; Bryant SC; Melton LJ; Vamvakas EC; Moore SB
Transfusion; 2001 Nov; 41(11):1413-20. PubMed ID: 11724988
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias.
Thedsawad A; Taka O; Wanachiwanawin W
Hematology; 2019 Dec; 24(1):208-214. PubMed ID: 30479186
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
Natukunda B; Schonewille H; van de Watering L; Brand A
Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
[TBL] [Abstract][Full Text] [Related]
10. Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome.
Singhal D; Kutyna MM; Chhetri R; Wee LYA; Hague S; Nath L; Nath SV; Sinha R; Wickham N; Lewis ID; Ross DM; Bardy PG; To LB; Reynolds J; Wood EM; Roxby DJ; Hiwase DK
Haematologica; 2017 Dec; 102(12):2021-2029. PubMed ID: 28983058
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Extended Typing On Red Blood Cell Alloimmunization in Transfused Patients.
Makarovska-Bojadzieva T; Velkova E; Blagoevska M
Open Access Maced J Med Sci; 2017 Apr; 5(2):107-111. PubMed ID: 28507611
[TBL] [Abstract][Full Text] [Related]
12. Regulatory B cells (CD19(+)CD38(hi)CD24(hi)) in alloimmunized and non-alloimmunized children with β-thalassemia major.
Zahran AM; Elsayh KI; Saad K; Embaby M; Ali AM
Blood Cells Mol Dis; 2016 Mar; 57():91-6. PubMed ID: 26852663
[TBL] [Abstract][Full Text] [Related]
13. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent.
Singer ST; Wu V; Mignacca R; Kuypers FA; Morel P; Vichinsky EP
Blood; 2000 Nov; 96(10):3369-73. PubMed ID: 11071629
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of erythrocyte alloimmunization in polytransfused patients.
Cruz Rde O; Mota MA; Conti FM; Pereira RA; Kutner JM; Aravechia MG; Castilho L
Einstein (Sao Paulo); 2011 Jun; 9(2):173-8. PubMed ID: 26760811
[TBL] [Abstract][Full Text] [Related]
15. Alloimmunization against platelets, granulocytes and erythrocytes in multi-transfused patients in Iranian population.
Younesi MR; Louni Aligoudarzi S; Bigdeli R; Lashgari M; Mazaheri H; Asgary V
Transfus Apher Sci; 2016 Oct; 55(2):205-211. PubMed ID: 27318433
[TBL] [Abstract][Full Text] [Related]
16. [Red blood cell alloimmunization among polytransfused patients in the National Hospital and University Center of Cotonou: about 51 cases].
Baglo T; Zohoun A; Agboton BL; Vigan J; Ayaka P; Anani L; Fall AOT; Gazard DK
Pan Afr Med J; 2021; 38():304. PubMed ID: 34178222
[TBL] [Abstract][Full Text] [Related]
17. Red blood cell alloimmunization mitigation strategies.
Hendrickson JE; Tormey CA; Shaz BH
Transfus Med Rev; 2014 Jul; 28(3):137-44. PubMed ID: 24928468
[TBL] [Abstract][Full Text] [Related]
18. Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study.
Adewoyin AS; Daramola OA; Ogbenna AA; Adeyemo TA
Immunohematology; 2021 Sep; 37(3):131-137. PubMed ID: 34591378
[TBL] [Abstract][Full Text] [Related]
19. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.
Castro O; Sandler SG; Houston-Yu P; Rana S
Transfusion; 2002 Jun; 42(6):684-90. PubMed ID: 12147019
[TBL] [Abstract][Full Text] [Related]
20. Skewed intracellular cytokine production of iNKT cells toward Th2-related responses in alloimmunized thalassemia patients.
Amirian N; Ranjbaran R; Shokrgozar N; Ataei S; Bazrafshan A; Sharifzadeh S
Cytokine; 2021 Apr; 140():155425. PubMed ID: 33508653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
